SALF
SALF is a Bergamo, Italy-based pharmaceutical manufacturer founded in 1921 that develops and produces medicines, veterinary drugs, and medical equipment through in-house research, employing 101-250 people.
- Company typePrivate
- Founded1921
- HeadquartersBergamo, Italy
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What SALF does
SALF is a privately-held Italian pharmaceutical manufacturer headquartered in Bergamo, Italy, founded in 1921. With a workforce of 101–250 employees, the company operates as a mid-sized for-profit manufacturer producing human medicines, veterinary drugs, and medical equipment, supported by in-house ongoing research. Its product portfolio therefore spans three regulated categories — ethical/generic pharmaceuticals, animal health products, and medical devices — implying an integrated R&D-to-manufacturing operating model within a single Italian site.
The company's business model is anchored in regulated B2B and B2B2C distribution of pharmaceutical and veterinary products and medical devices, but no specific pricing model, channel structure, customer mix, or revenue mechanic was returned in the available data. SALF's public website (salfspa.it) did not yield substantive content during this data collection — the source page displayed only a loading/verification message — and consequently fields covering products, certifications, partnerships, management team, funding, M&A, AI capability, and customer base returned no values.
Given the thinness of the input, claims about market positioning, revenue scale, geographic footprint, capital structure, or competitive strategy cannot be substantiated beyond the firmographic facts above. Any further analysis would require access to the company's filings, distributor agreements, or audited financials, none of which were provided.
SALF firmographics
Firmographics- Name
- SALF
- Website
- https://salfspa.it
- Company type
- Private
- Founded year
- 1921
- Headcount range
- 101–250 employees
- Short description
- SALF is a Bergamo, Italy-based pharmaceutical manufacturer founded in 1921 that develops and produces medicines, veterinary drugs, and medical equipment through in-house research, employing 101-250 people.
- Ownership category
- akta.pro rank
SALF industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)
- akta.pro secondary industry
- Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)
Keywords
Where SALF is headquartered
LocationHeadquarters
- HQ city
- Bergamo
- HQ country
- Italy
- HQ region
- Europe
Markets served
SALF business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Others
SALF product offering
Product offeringCore offering
SALF is a pharmaceutical manufacturer that develops, produces, and supplies human medicines, veterinary drugs, and medical equipment. The company's offering is built on ongoing in-house pharmaceutical research, formulation, and manufacturing capabilities, delivering finished pharmaceutical and medical products to healthcare and animal health markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Human medicines Pharmaceutical products manufactured by SALF for human therapeutic use, produced through ongoing research and produced at the company's Bergamo, Italy facility for distribution to healthcare buyers.
- Veterinary drugs Veterinary pharmaceutical products manufactured by SALF for animal health applications, produced in-house and supplied to veterinary clinics, animal operations, and animal-health distributors.
- Medical equipment Medical devices and equipment manufactured by SALF as part of its product portfolio, intended for healthcare facilities and medical supply buyers.
Companies that use SALF
Customer profileIdeal customer profiles1 record
SALF technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SALF competitors and assessment
Company assessmentEmerging players
- Heska (now part of Mars Petcare / Antech): Veterinary diagnostics and specialty medical device company. Comparable to SALF's medical equipment line in the animal-health segment.
Regional players
- Menarini Group: Italy-headquartered private pharmaceutical company with diversified pharma, diagnostics, and healthcare businesses. Comparable as a large privately held Italian peer with diversified healthcare manufacturing.
- Chiesi Farmaceutici: Private Italian pharmaceutical group with R&D-driven specialty pharma and rare-disease franchises. Comparable to SALF in being a privately held, R&D-active Italian pharma manufacturer.
- Recordati: Italy-based mid-cap pharmaceutical company focused on specialty and rare diseases. Comparable as a fellow Italian mid-size pharma manufacturer operating from the same domestic cluster.
Direct peers
- Ceva Santé Animale: French global veterinary pharmaceutical group combining veterinary drugs, vaccines, and specialty pharma. Comparable to SALF's mix of veterinary drugs and broader pharmaceutical manufacturing in Europe.
- Dechra Pharmaceuticals: UK-based specialty veterinary pharmaceuticals company focused on companion-animal therapeutics. Comparable to SALF in targeting specialty veterinary drug segments with a European base.
- Virbac: France-based global veterinary pharmaceutical company with a diversified animal-health and pharmaceutical product portfolio. Closely comparable to SALF in combining veterinary drugs with adjacent pharmaceutical offerings at a similar mid-cap scale.
- Vetoquinol: Independent European veterinary pharmaceutical company headquartered in France. Comparable mid-size European competitor with overlapping veterinary drug and animal health portfolios.
Broad incumbents
- Zoetis: Global leader in animal health and veterinary pharmaceuticals. Directly comparable to SALF's veterinary drugs line and serves as the scale benchmark SALF competes against in the veterinary segment.
- Elanco Animal Health: Large global animal health company with a broad veterinary pharmaceutical and vaccine portfolio. Comparable to SALF's veterinary drugs line and sets the competitive benchmark for global veterinary scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
SALF social profiles
Digital presenceSALF financial estimates
Financial estimateRevenue estimate
Valuation estimate
SALF leadership team
Management profileNumber of profiles
SALF funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SALF M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SALF
What does SALF do?
SALF is a pharmaceutical manufacturer that develops, produces, and supplies human medicines, veterinary drugs, and medical equipment. The company's offering is built on ongoing in-house pharmaceutical research, formulation, and manufacturing capabilities, delivering finished pharmaceutical and medical products to healthcare and animal health markets.
When was SALF founded?
SALF was founded in 1921. It employs 101 to 250 people.
Where is SALF based?
SALF is headquartered in Bergamo, Italy, in the Europe region.
Who are SALF's main competitors?
Heska (now part of Mars Petcare / Antech) is listed as an emerging player. Regional players are Menarini Group, Chiesi Farmaceutici and Recordati. Direct peers are Ceva Santé Animale, Dechra Pharmaceuticals, Virbac and Vetoquinol. Broad incumbents are Zoetis and Elanco Animal Health.
Does SALF have an API?
No public API is recorded for SALF.
What industry is SALF in?
SALF's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAMAEAG, Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid), with a secondary code of HLAMAFAF, Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers). Its NAICS code is 325412 and its SIC code is 2834.